Call Us On 0207 152 4473

For a FREE Hair Assessment Call

PLEASE CALL 0207 152 4473


BLOG

BIOSTIM HAIR LOSS TREATMENT: EXCLUSIVE TO THE HAIR CENTRE [ LONDON TRICHOLOGISTS ]

17 Aug 2009, by haircentre in Uncategorized

confused-woman1

Description

A combination of naturally occurring 5-reductase inhibitors with added multivitamin complex for the stimulation of hair follicles suppressed by the action of Androgens in cases of androgenic alopecia.

biostim

Contents

Aqua, Sabal Serrulata ext, Propylene Glycol, PEG-35 Castor Oil. Polysorbate 20, Aesculus Hipposastanum etx, Retinyl Palmitate, Tocopherol, PABA, Inositol, Calcium Pantothenate, Linoleic Acid, Biotin, Urea, Allantoin, Phenoxyethanol, Methyl Paraben, Butyl Paraben, Ethyl Paraben, Propyl Paraben, Isobutyl Paraben.

Mode of Action

5-reductase inhibitors act as anti-androgens, reducing the levels of di-hydroxy testosterone (DHT), decreasing the levels of androgen activity at the target site.  The consequent reduced levels of DHT stabilise or reduce the level of atrophy of the hair follicle and shaft in the genetically determined areas in the treatment of androgenic alopecia.  The hair growth period (anagen) is prolonged and promotes increased hair growth and density.

Clinical Trials

Clinical trials of the natural ingredients have established anti-androgen activity and the ability to suppress di-hydroxy testosterone (DHT) formation, beneficial in cases of androgenic alopecia.  The increased dermal papilla activity increases hair cell production and proliferation, increases the number of hairs in the anagen phase and increases the A/T (anagen/telogen ration). 

In order to treat hair loss effectively we would recommend that you have a diagnosis made as soon as possible by one of our experienced Westminster Trichologists. Stress can be an aggravator in almost all cases of hair loss and an accurate diagnosis will always, at the very least, take some of the stress away from you.

Do you have Hair Loss Problems, read our Hair Loss Help

Please like & share:
NO COMMENT

Sorry, the comment form is closed at this time.